Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems
Fabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.
Neuropharmacology
|
July 16, 2011
In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE)
Elisabetta Perdona', Vivian J A Costantini, Michela Tessari, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2010
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3
Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
February 28, 2004
3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I
Fabrizio Micheli, Romano Di Fabio, Roberto Benedetti, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems
Fabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.
Journal of Medicinal Chemistry
|
September 16, 2010
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists
Fabrizio Micheli, Luca Arista, Barbara Bertani, et al.
Journal of Medicinal Chemistry
|
September 29, 2006
A critical assessment of docking programs and scoring functions
Gregory L Warren, C Webster Andrews, Anna-Maria Capelli, et al.
Journal of Medicinal Chemistry
|
April 5, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
Elisabetta Armani, Andrea Rizzi, Nicolò Iotti, et al.
Bioorganic & Medicinal Chemistry
|
December 10, 2002
Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists
Fabrizio Micheli, Romano Di Fabio, Paolo Cavanni, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis
Marta Giuliani, Andrea Rizzi, Mafalda Pagano, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems
Fabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.
Neuropharmacology
|
July 16, 2011
In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE)
Elisabetta Perdona', Vivian J A Costantini, Michela Tessari, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2010
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3
Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
February 28, 2004
3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I
Fabrizio Micheli, Romano Di Fabio, Roberto Benedetti, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems
Fabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.
Journal of Medicinal Chemistry
|
September 16, 2010
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists
Fabrizio Micheli, Luca Arista, Barbara Bertani, et al.
Journal of Medicinal Chemistry
|
September 29, 2006
A critical assessment of docking programs and scoring functions
Gregory L Warren, C Webster Andrews, Anna-Maria Capelli, et al.
Journal of Medicinal Chemistry
|
April 5, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
Elisabetta Armani, Andrea Rizzi, Nicolò Iotti, et al.
Bioorganic & Medicinal Chemistry
|
December 10, 2002
Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists
Fabrizio Micheli, Romano Di Fabio, Paolo Cavanni, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis
Marta Giuliani, Andrea Rizzi, Mafalda Pagano, et al.
Page
of 4